DUBLIN–(BUSINESS WIRE)–The “Spectacle Lens Market – Growth, Trends, Covid-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The Spectacle Lens market was valued at USD 45,395 million in 2020, and it i…
Author: Business Wire
Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape Report 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape …
CURACLE und Théa geben Lizenzierungs- und Kooperationsvereinbarung für die Entwicklung und Vermarktung einer oral verabreichten Behandlung des diabetischen Makulaödems und der feuchten AMD bekannt
SEOUL, Südkorea–(BUSINESS WIRE)–CURACLE, ein in Korea ansässiges biopharmazeutisches Unternehmen, gab heute die Unterzeichnung einer exklusiven Lizenz- und Kooperationsvereinbarung mit Théa Open Innovation bekannt, dem Schwesterunternehmen von Théa, …
CURACLE e Théa annunciano un accordo di licenza e collaborazione per lo sviluppo e la commercializzazione di un trattamento a somministrazione orale per l’edema maculare diabetico e la degenerazione maculare senile essudativa
SEUL, Corea del Sud–(BUSINESS WIRE)–CURACLE, una società biofarmaceutica coreana, ha annunciato quest’oggi di aver concluso un accordo di licenza e collaborazione esclusivo con Théa Open Innovation, la società sorella di Théa, azienda di oftalmologia…
CURACLE and Théa Announce Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD
SEOUL, South Korea–(BUSINESS WIRE)–CURACLE signs tech licensing and collaboration deal with leading independent European ophthalmology company Théa in diabetic macular edema and wet-AMD
National Vision Holdings, Inc. Announces Third Quarter 2021 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its third quarter 2021 financial results before the market opens on Wednesday, November 10, 2021. The Company will host a confer…
Europe Macular Edema Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecast, Drug Forecasts, and Shares 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Macular Edema Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Macular Edema Market and Competitive Landscape – 2021, provides comprehensive insights into M…
Europe Glaucoma Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecast, Drug Forecasts, and Shares 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Glaucoma Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Glaucoma Market and Competitive Landscape – 2021, provides comprehensive insights into Glaucoma pi…
Une étude révèle des preuves accablantes indiquant que le daltonisme entrave l'apprentissage à l'école, rapporte EnChroma
BERKELEY, Californie–(BUSINESS WIRE)–EnChroma, créateur de lunettes contre le daltonisme, a publié aujourd’hui les résultats d’une étude sans précédent, qui démontre clairement l’effet négatif de cette anomalie de la vision sur l’apprentissage de mil…
Studie findet überwältigende Beweise, dass Farbenblindheit schulisches Lernen beeinträchtigt, berichtet EnChroma
BERKELEY, Kalifornien–(BUSINESS WIRE)–EnChroma – Schöpfer von Brillen für Farbenblindheit – hat heute die Ergebnisse einer wegweisenden Studie veröffentlicht, aus der eindeutig die negativen Auswirkungen von Farbenblindheit auf das Lernen für Million…
OpRegen® Data Update to Be Featured at 2021 American Academy of Ophthalmology Annual Meeting in Presentation by Michael S. Ip, M.D.
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today th…
Mastercard Introduces Accessible Card for Blind and Partially Sighted People
PURCHASE, N.Y.–(BUSINESS WIRE)–Mastercard today introduced a new accessible card standard for blind and partially sighted people, called the Touch Card.
Resumen: Un estudio presenta pruebas abrumadoras de que el daltonismo dificulta el aprendizaje en el colegio, según EnChroma
BERKELEY, Calif.–(BUSINESS WIRE)–EnChroma -creadores de gafas para el daltonismo- ha dado a conocer hoy los resultados de un estudio histórico que demuestra claramente el efecto negativo que tiene el daltonismo en el aprendizaje de millones de estudi…
Samenvatting: Studie vindt overweldigend bewijs dat kleurenblindheid het leren op school belemmert, meldt EnChroma
BERKELEY, Californië–(BUSINESS WIRE)–EnChroma – makers van brillen voor kleurenblindheid – heeft vandaag de resultaten vrijgegeven van een baanbrekend onderzoek dat duidelijk het negatieve effect van kleurenblindheid op het leren van miljoenen studen…
Riassunto: Secondo quanto riferito da EnChroma, uno studio prova in modo inequivocabile che il daltonismo ostacola l’apprendimento scolastico
BERKELEY, California–(BUSINESS WIRE)–EnChroma, l’azienda cui si deve la creazione di occhiali per le persone affette da daltonismo, ha pubblicato oggi i risultati di un importante studio che dimostra chiaramente gli effetti negativi del daltonismo su…
Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it will release its financial results for the third quarter and nine months ended September 30, 2021, on Tue…
First Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump System
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today announced that its patented Cartridge Pump System (CPS), designed for the multi…
Study Finds Overwhelming Evidence That Color Blindness Hinders Learning in School, Reports EnChroma
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–Study Finds Overwhelming Evidence that Color Blindness Hinders Learning in School, Reports EnChroma. Variety of challenges for color blind students.
Global Macular Edema Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Macular Edema Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Macular Edema Market and Competitive Landscape – 2021, provides comprehensive insights into M…
FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo™ (ranibizumab injection) 100 mg/mL for intravitreal…